PD L1 News and Research

RSS
Sorrento Therapeutics acquires Concortis Biosystems

Sorrento Therapeutics acquires Concortis Biosystems

Tumor-infiltrating lymphocytes may be good biomarker of response to trastuzumab in breast cancer

Tumor-infiltrating lymphocytes may be good biomarker of response to trastuzumab in breast cancer

Experimental drug effective in treating patients with non-small cell lung cancer

Experimental drug effective in treating patients with non-small cell lung cancer

Interim data from Phase 1B trial of an investigational anti-PD-1 immunotherapy in patients with previously-treated NSCLC announced by Merck

Interim data from Phase 1B trial of an investigational anti-PD-1 immunotherapy in patients with previously-treated NSCLC announced by Merck

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

Cancer immunotherapies promise to be a new tool in fight against cancer

Cancer immunotherapies promise to be a new tool in fight against cancer

Cancer immunotherapy shows promise in treating patients with metastatic tumors

Cancer immunotherapy shows promise in treating patients with metastatic tumors

New drug shows promising results with manageable side effects for treating melanoma

New drug shows promising results with manageable side effects for treating melanoma

Lambrolizumab shows significant antitumor activity in patients with advanced melanoma

Lambrolizumab shows significant antitumor activity in patients with advanced melanoma

CRI, MedImmune partner to advance cancer immunotherapy research

CRI, MedImmune partner to advance cancer immunotherapy research

New results describe development of DC cancer vaccine with enhanced immunogenic potential

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Antibody that blocks programmed cell death benefits cancer patients

Antibody that blocks programmed cell death benefits cancer patients

Interim results from Bristol-Myers Squibb’s BMS-936558 Phase 1 study on NSCLC, MM and RCC

Interim results from Bristol-Myers Squibb’s BMS-936558 Phase 1 study on NSCLC, MM and RCC

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

A melanoma cloaking protein

A melanoma cloaking protein

Melanomas express B7-H1 protein to hide from T-cells

Melanomas express B7-H1 protein to hide from T-cells

Genetically engineered pigs may help overcome donor organ shortage

Genetically engineered pigs may help overcome donor organ shortage

New gene therapy may cure Type 1 diabetes

New gene therapy may cure Type 1 diabetes